Menu
Recruiting NCT06511752

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

Early Phase I Interventional Alzheimer Disease Dementia Primary Progressive Aphasia Aphasia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Psychosocial educational, support group and implementation of strategies.
Who it may be relevant to
Registry conditions: Alzheimer Disease, Dementia, Primary Progressive Aphasia, Aphasia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Educational Support Group Program for Carepartners of Bilingual and Spanish-speaking Persons With Progressive Forms of Aphasia and for Persons With Progressive Forms of Aphasia

Overview

The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function. Analysis of study-specific surveys and semi-structured interviews will provide qualitative data regarding outcomes. Before beginning the education and support group, focus groups will be run in order to set priorities for the themes to be included in the education program. Participants will join via tele-based means if preferred and these participants may reside in the United States, or internationally including Mexico and Spain.

Detailed description

Two educational/support group routes will be offered:

1. Progressive aphasia (PA) educational/support group or 2. Caregiver educational support group with an implementation phase (including their partner with PA).

The caregiver educational support group path will be delivered in two phases, whereas the PA educational support group path will only consist of the first phase. The first phase of the caregiver educational support group will focus on the educational support group and the second phase will consist of implementation and practice of strategies with feedback provided by the clinician.

The educational/support groups (Routes 1 and 2) will include opportunities for discussion of issues related to language-led dementia or progressive aphasia (e.g., coping with changes in cognition and language, use of strategies for effective communication) and education regarding the disorder provided by relevant experts (e.g., speech-language pathologists, licensed professional counselors), separately for carepartners and individuals with progressive aphasia.

The implementation phase (Route 2, only) will allow for practice of strategies and skills learned in the first phase.

The total amount of time participants will be involved in the study will be 9 months, inclusive of follow-up.

Phase 1. Timeline for the support group portion of the study: Participants will complete pre-treatment measures during a period of 1-2 weeks prior to their first meeting. After four months of twice monthly meetings, post-treatment measures will be completed within 1-2 weeks of treatment completion. Follow-up evaluation will take place at 3-months post-treatment.

Phase 2. Timeline for the implementation/dyad training portion of the study: Post-treatment assessment from Phase 1 will serve as pre-treatment assessment for Phase 2. Treatment sessions will be held once weekly for 4 weeks, and post-treatment assessment will be completed within 1-2 weeks of phase 2 treatment completion. Follow-up evaluation will take place at 3-months post-treatment.

Interventions

  • Behavioral Psychosocial educational, support group and implementation of strategies
    Psychosocial educational, support group and implementation of strategies

Primary outcome measures

  • Treatment/Acceptability Survey [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
Secondary outcome measures (12)
  • Acceptability Measure [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • % participants who complete intervention, % sessions completed [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • % completion of homework [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Retention [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Aphasia Impact Questionnaire [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Mini-Mental State Exam [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Quick Aphasia Battery [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Stroke and Aphasia Quality of Life Scale- 39 [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Progressive Aphasia Severity Scale (PASS) [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • The Neuropsychiatric Inventory [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Clinical Dementia Rating Scale (CDR) [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]
  • Quality of the Caregiver Patient Relationship (QCPR) [Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment]

Eligibility criteria

Inclusion criteria

All participants must:

  • speak Spanish and/or English (although participants may speak other languages in addition to Spanish and/or English)
  • identify as Hispanic and/or Latinx,
  • or their spouse/family member with PA identifies as Hispanic and/or Latinx
  • see and hear well enough to participate
  • have access to a computer or mobile device with video capability
  • have an internet connection

Additional inclusion criteria for PA/ language-led dementia support group participants:

  • Individuals with PA:
  • Has a diagnosis of PA, or language-led dementia, and aphasia is one of the primary causes of difficulty with activities of daily living
  • Aware of language difficulties and willing to discuss them
  • Able to actively engage in group discussion and complete activities with minimal support
  • Able to regularly attend meetings
  • Willing to follow the rules of the support group for interacting with others respectfully

Additional inclusion criteria for care partner support group plus implementation phase participants:

  • Individuals with PA:
  • Diagnosis of aphasia or dementia that is progressive in nature, and aphasia is one of the primary causes of difficulty with activities of daily living
  • Have some ability to communicate and understand communication in order to participate in training sessions
  • Are functionally able to engage in training sessions (e.g., able to maintain some attention, minimal challenging behavior that would cause disruption)
  • Have a care partner who also consents to participating in the project
  • Care partners:
  • Self-identification as a caregiver of an individual with a diagnosis of PA or language-led dementia
  • Willing to discuss caregiving for individuals with PA/ language-led dementia
  • Able to regularly attend meetings
  • Willing to follow the rules of the support group for interacting with others respectfully

Exclusion criteria

  • Beyond the inclusion criteria included above, no additional exclusion criteria apply

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of Texas at Austin — Austin

Identifiers

NCT: NCT06511752 · STUDY00005541

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗